Clinical Trials Directory

Trials / Conditions / Haematological Malignancies

Haematological Malignancies

10 registered clinical trials studyying Haematological Malignancies — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingClinical Efficacy of Platelet Transfusion
NCT06805097
Centre Hospitalier Universitaire de Besancon—
RecruitingProof of Concept to Assess the Feasibility of a Decentralised Pathway Coordinated by the Advanced Practice Nur
NCT06797037
Institut Claudius RegaudN/A
RecruitingCryopreserved Ovarian Tissue Transplantation in Patients Who Have Survived Sarcomas and Hematological Tumors
NCT06829654
IRCCS Azienda Ospedaliero-Universitaria di BolognaN/A
CompletedMass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies
NCT05148806
Imperial College London—
TerminatedStudy of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies
NCT04865419
AstraZenecaPhase 1
CompletedInfusion of Depleted T Cells Following Unrelated Donor Stem Cell Transplant (ICAT)
NCT01827579
University College, LondonPhase 1 / Phase 2
SuspendedStudy of Adoptive Immunotherapy With Donor-derived CMV-specific T Cells for Recipients of Allo-HSCT
NCT02988258
University College, LondonPhase 1
UnknownStudy of Non-Myeloablative Haplo-identical Haematopoietic Stem Cell Transplantation in Patients With Haematolo
NCT01719341
National University Hospital, Singapore—
WithdrawnCD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation
NCT01336478
Imperial College LondonPhase 1
TerminatedA Phase I, Dose-escalation Study of AS703569 Given Orally to Subjects With Haematological Malignancies
NCT01080664
EMD SeronoPhase 1